Lung Cancer

Previously treated patients with advanced small cell lung cancer (SCLC) benefitted from immunotherapy.

Merger combines more than 30 years of patient-centered expertise to "Empower Everyone, Ignore No One."

Merger combines more than 30 years of patient-centered expertise to "Empower Everyone, Ignore No One."

Patients with previously treated, advanced NSCLC who received Opdivo therapy experienced a survival benefit over many years, according to a pooled analysis of four studies.

Liquid biopsies may be less invasive and faster in determining the genetics of a tumor — and with high accuracy — among those diagnosed with non-small cell lung cancer.

Going through a cancer diagnosis and treatment is so difficult. Thanks to my care team suggesting proton therapy, I never felt like my life became consumed by my lung cancer diagnosis.